| Japanese to English: コンビニATM（抜粋） | |
Source text - Japanese
大銀行が合併やらリストラやら自分たちの都合で、どんどん店舗を減らし、記者の近所の無人ATM（現金自動出入機）もついに姿を消した。それに取って代わるようにここ数年で急激に普及し、一気に利便性が高まったのがコンビニATMだ。
とはいえ、自分の銀行のATMなら引き出し無料（平日昼間帯）でも、コンビニは一回１０５円の手数料。夜間や土日の時間外なら２１０円だ。記者はコンビニで小額をちょこちょこっと引き出すものだから、毎月２千円近く負担している。たまったものではない。
| Translation - English
Big banks have decreased the number of their branch locations due to their self-centered reasons, such as mergers and corporate restructuring, and the ATM (automated teller machine) in my neighborhood has finally disappeared as a result. In contrast to this trend, what have become increasingly prevalent and convenient in these several years are the ATMs located in convenience stores.
However, while there is no fee charged for a cash withdrawal made during the daytime on a weekday at ATMs of one's own banks, at convenience stores there is a fee of 105 yen for the same transaction, and it jumps to 210 yen during evening hours and weekends. Since I frequently withdraw a small amount at a time in convenience stores, I end up paying about 2000 yen in fees every month. It is really frustrating.
|
| English to Japanese: An open source approach for medical research (part) | |
Source text - English
Can goodwill, aggregated over the internet, produce good medicine? The current approach to drug discovery works up to a point, but it is far from perfect. It is costly to develop medicines and get regulatory approval. The patent system can foreclose new uses or enhancements by outside researchers. And there has to be a consumer willing (or able) to pay for the resulting drugs, in order to justify the cost of drug development. Pharmaceutical companies have little incentive to develop treatments for diseases that particularly afflict the poor, for example, since the people who need such treatments most may not be able to afford them. | Translation - Japanese
インターネット上で蓄積される人々の善意で、良い薬を生み出すことは可能だろうか。現在用いられている新薬発見の手段は、ある程度の成果を出してはいるものの、まだ完璧と呼べるには程遠い。新薬を開発し行政認可を得るには多大な費用がかかる。特許制度は外部研究者による特許保護下の薬の新利用や改良を妨げている。また、新薬開発にかかる費用を正当化させるには、その薬を購入できる消費者が存在しなければならない。更に、最も薬を必要とする人々に資金的余裕がない例もあり、貧困層を特に襲うような病気に対する新しい療法を開発する動機が医薬品会社には乏しい。 |
